Physician profile
Tyler Robert King
NPI 1740843283
$6,462.17
in general payments reported to CMS, 2019-2025
11 companies · $1,205 in 2025
The $1,205 reported for 2025 was more than what 88% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $103 · 2021: $423 · 2022: $2,448 · 2023: $1,452 · 2024: $588 · 2025: $1,205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,505 · Food and Beverage: $1,483 · Education: $232 · Gift: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,505.13 |
| Food and Beverage | $1,483.28 |
| Education | $231.89 |
| Gift | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,891.95 | 2021-2024 | Na, Smartlock, Vsp System, Vsp Cranial |
| Zimvie INC. | $1,244.70 | 2024-2025 | |
| Acumed LLC | $336.24 | 2023-2024 | Osteomed, Accuplate Patient-Specific Plate |
| Depuy Synthes Sales INC. | $278.11 | 2021-2024 | Trumatch |
| Zimmer Biomet Holdings, INC. | $226.84 | 2019-2020 | |
| Straumann USA LLC | $157.90 | 2024-2025 | |
| Acell, INC. | $119.25 | 2019 | |
| Axogen | $116.91 | 2021 | |
| Medical Device Business Services, INC. | $32.75 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $30.33 | 2023 | Exparel |
| Geistlich Pharma, North America, INC. | $27.19 | 2024 | Geistlich Bio-Gide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.